ArticleAmerican journal of translational research2024
Predictive value of IL-10 and GFPA for postoperative prognosis in patients with brain glioma.
Article in American journal of translational research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Correlation between serum GFAP and 3-NT levels and the degree of neuronal injury in patients with glioma after surgery, and its diagnostic value.Biomarkers in medicine · 2025Article
- Analysis of Pro-Inflammatory and Anti-Inflammatory Cytokine Serum Concentrations in Pediatric Patients with Neuroblastoma: A Preliminary Study.Biomedicines · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the prognostic value of interleukin (IL)-10 and glial fibrillary acidic protein (GFPA) in patients with brain glioma following surgery.
methodsThe clinical data of 75 patients with brain glioma (Observation group) who were treated at the Central Hospital Affiliated with Shandong First Medical University were retrospectively analyzed. Additionally, 40 healthy volunteers who underwent physical examination during the same period were selected as the control group. The serum levels of IL-10 and GFPA were compared between the observation group and the control group as well as across different clinicopathological characteristics of the glioma patients. Multivariate logistic regression analysis was used to identify factors influencing postoperative brain injury in patients with brain gliomas. Receiver operating characteristic (ROC) curve was used to analyze the predictive value of preoperative IL-10 and GFPA levels for patient prognosis.
resultsSerum levels of IL-10 and GFPA in the observation group were significantly higher than those in the control group (all P<0.05). Before surgery, there was no significant differences in serum IL-10 and GFPA levels between the mild- and moderate-severity group; however, postoperatively, both markers were elevated in the moderate-severity group compared to the mild group (all P<0.05). Patients with World Health Organization (WHO) grade III-IV, mutant protein 53 (P53) genotype, and high Ki-67 expression exhibited higher IL-10 levels than their counter parts. However, the trends were conversely observed for GFAP. Pearson correlation analysis showed that IL-10 and GFPA levels were negatively associated with Glasgow Coma Scale (GCS) scores after surgery. Logistic regression analysis showed that IL-10 and GFPA were the independent risk factors for postoperative brain injury in glioma patients. The area under the curve (AUC) of IL-10 and GFPA for predicting the postoperative brain injury in glioma patients were 0.718 and 0.745, respectively; while their combined detection achieved an AUC of 0.835, which was significantly higher than each single detection.
conclusionElevated serum IL-10 and GFPA levels in patients with brain glioma are associated with postoperative brain injury. IL-10 and GFPA can serve as valuable indicators for the prognostic evaluation of patients with brain gliomas.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.